WA - Trends in the use of Opioid Agonist Treatment in Australia, 2013-2022
Resource Type:
A recent development in the treatment of opioid dependence is the introduction of long-acting injectable (LAI) formulations of buprenorphine.
Technical Reports
VIC - Trends in the use of Opioid Agonist Treatment in Australia, 2013-2022
Resource Type:
A recent development in the treatment of opioid dependence is the introduction of long-acting injectable (LAI) formulations of buprenorphine.
TAS - Trends in the use of Opioid Agonist Treatment in Australia, 2013-2022
Resource Type:
A recent development in the treatment of opioid dependence is the introduction of long-acting injectable (LAI) formulations of buprenorphine.
NT - Trends in the use of Opioid Agonist Treatment in Australia, 2013-2022
Resource Type:
A recent development in the treatment of opioid dependence is the introduction of long-acting injectable (LAI) formulations of buprenorphine.
SA - Trends in the use of Opioid Agonist Treatment in Australia, 2013-2022
Resource Type:
A recent development in the treatment of opioid dependence is the introduction of long-acting injectable (LAI) formulations of buprenorphine.
QLD - Trends in the use of Opioid Agonist Treatment in Australia, 2013-2022
Resource Type:
A recent development in the treatment of opioid dependence is the introduction of long-acting injectable (LAI) formulations of buprenorphine.
NSW - Trends in the use of Opioid Agonist Treatment in Australia, 2013-2022
Resource Type:
A recent development in the treatment of opioid dependence is the introduction of long-acting injectable (LAI) formulations of buprenorphine.
Real-world dosing intervals of long-acting buprenorphine for opioid agonist treatment
Resource Type:
A recent development in the treatment of opioid dependence is the introduction of long-acting injectable (LAI) formulations of buprenorphine.
ACT - Trends in the use of Opioid Agonist Treatment in Australia, 2013-2022
Resource Type:
A recent development in the treatment of opioid dependence is the introduction of long-acting injectable (LAI) formulations of buprenorphine.
Alcohol-related behaviours, beliefs, and knowledge regarding cancer risk related to alcohol in the New South Wales LGBTQ+ community
Resource Type:
Sexuality and gender diverse (LGBTQ+) people are a priority for cancer control due to differing experience of risk factors for cancer and participation in cancer screening services compared to cisg